Home › Products › Infectious Disease › Revugam 25mg Tablet
Revugam 25mg Tablet
Salt Composition: ELTROMBOPAG
- Manufacturer: BHARAT SERUMS & VACCINES LTD
- Pack Size: 7 TABLET(s) IN A STRIP
- Dosage Form: TABLET
- Strength: 25MG
- Prescription Required
- Storage: Store Revugam 25mg Tablet at room temperature (25°C). Keep the medicine out of reach of children and pets.
₹1315.00₹1546.88
Inclusive of all taxes
Product Introduction
Revugam 25mg Tablet is an anticoagulant medication in the thrombopoietin (TPO) receptor agonist class, containing eltrombopag as the active ingredient. It is indicated for treating low platelet counts associated with primary immune thrombocytopenia (ITP) or hepatitis C (HCV) infection. ITP is an autoimmune disorder in which the immune system destroys platelets, which are blood cells essential for clotting and protecting blood vessel walls. Low platelet levels can result in severe bleeding and bruising. The tablet is also used in adults for low blood counts caused by severe aplastic anaemia, a serious blood disease occurring when the bone marrow fails to produce adequate new blood cells.
This drug should not be used in individuals with known hypersensitivity or allergic reactions to the active ingredient or its components. Allergic reactions may range from mild to severe and include symptoms such as rash, itching, swelling, dizziness, or difficulty breathing. Revugam 25mg Tablet is contraindicated in patients with severe liver impairment or active liver disease. The medication can potentially cause hepatotoxicity, as indicated by increased liver enzymes and bilirubin levels. Use in individuals with severe liver disease may further worsen liver function, so caution is advised.
Your doctor will recommend cataract screening. Regular eye testing should be arranged if you do not have routine examinations. You may also be checked for bleeding in or around your retina, the light-sensitive layer of cells at the back of the eye. If you discontinue this tablet, your blood platelet count is likely to fall again within several days. Platelet count will be monitored, and your doctor will discuss appropriate precautions. A very high blood platelet count may increase the risk of blood clotting, although blood clots can form with normal or even low platelet counts. Your doctor will adjust your dose to ensure your platelet count does not become too high.
Do not take this tablet with dairy products or drinks, as calcium in these items affects medicine absorption. Use effective birth control during treatment, and inform your doctor if you become pregnant. Revugam 25mg Tablet is not advised for children under one year with ITP. It is also not recommended for patients under 18 years with low platelet counts caused by hepatitis C or severe aplastic anaemia. Inform your doctor if you are taking, have recently taken, or might take other medicines, including those obtained without prescription and vitamins.
Uses
Revugam 25mg Tablet is used to treat, Low platelet counts are caused by primary immune thrombocytopenia (ITP) or hepatitis C virus (HCV) infection. Severe aplastic anemia
How it works
Revugam 25mg Tablet stimulate megakaryocytes (the large bone marrow cells) responsible for producing platelets. By raising the number of platelets in the blood, this drug prevents bleeding and bruising.
How to Use
It is an orally available prescription drug. Your doctor will decide the dose and duration of the drug based on the disease condition and other factors. Always take an Revugam 25mg Tablet as prescribed by your doctor. Take the tablet with or without food. Do not chew, crush, or break the tablet. Swallow the whole tablet with water.
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. Common Nausea Diarrhea, abdominal pain Common cold Cough Respiratory tract infection Back pain High temperature, cough Loss of appetite Hair loss Swelling in feet or hands Headache, dizziness Mouth and throat pain Joint pain
Expert Tips
Ensure that in the 2 hours after or 4 hours before you take this medication, you donât consume dairy foods (such as cheese or butter), milk or milkshakes, antacids, and supplements containing iron, aluminum, magnesium, calcium, selenium, zinc, or calcium. If you forget to take the Revugam 25mg Tablet, take your next dose at the usual time. Do not take more than one dose of this drug daily. Donât stop taking this tablet without talking to your doctor. If your doctor advises you to stop treatment, your platelet count will be checked each week for four weeks. If you have any doubts regarding the use of this medicine, ask your doctor.
References
- Novartis Pharmaceuticals UK Limited, Electronic medicines compendium (EMC), [ Revised on Jan 2022] [Accessed on 22 May 2023], https://www.medicines.org.uk/emc/files/pil.508.pdf
- GlaxoSmithKline, US Food and Drug Administration, [ Revised on October 2008] [Accessed on 22 May 2023], https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/022291lbl.pdf
- Revolade, Annex I summary of Product Characteristics - European Medicines Agency. Available at: https://www.ema.europa.eu/en/documents/product-information/revolade-epar-product-information_en.pdf [Accessed on 22 May 2023].
Safety Advice
Pregnancy: unsafe Revugam 25mg Tablet is not recommended for pregnant patients because it may cause fetal harm. You must inform your doctor if you are pregnant, suspecting, or planning to get pregnant during the treatment.
Lungs: Consult your doctor It is unknown whether Revugam 25mg Tablet can be prescribed for patients with lung problems. Consult your doctor if you have any lung diseases before starting the treatment.
Breastfeeding: unsafe It is not known whether Revugam 25mg Tablet passes into breast milk. If you are breastfeeding or planning to breastfeed, tell your doctor.
Disclaimer
The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.